Sequana Medical Investor Presentation December 2022

Sequana Medical presents its pioneering therapeutic solutions for treating drug-resistant fluid overload in patients with liver disease, heart failure, and cancer. The presentation covers the company's lead product the alfapump® system and emerging DSR® therapy, detailing clinical development status and regulatory pathways in Europe and other markets.